Reuters broke the information that Merck, the German healthcare and expertise group, is in superior talks to accumulate U.S. most cancers and uncommon ailments drugmaker Springworks Therapeutics. Springworks’ shares jumped almost 49% on the Reuters story to the touch its highest stage since April 2022. Merck later launched a press release confirming the Reuters scoop.
The publish Germany’s Merck in advanced talks to acquire US biotech firm Springworks appeared first on Reuters Best.
Source link